Journal Title：International Clinical Psychopharmacology

International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.

A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.

《國際臨床精神藥理學》在整個精神藥理學領域為研究與臨床實踐提供了重要聯系。它報道了對人類受試者（包括健康志愿者和患者）的研究，這些研究將藥物對心理過程的影響聯系起來。

該期刊的主要目標是發表經過全面審查的論文，闡明精神藥物研究如何增進我們對精神藥理學的了解。為此，該期刊發表了早期 I 期和 II 期研究的結果，以及 II 期和 IV 期精神藥物對照臨床試驗的結果。其他主題包括精神藥物處方和服藥的流行病學、精神藥物的社會學（包括依從性）以及對這些化合物的安全性和不良反應的研究。

International Clinical Psychopharmacology創刊于1986年，由Lippincott Williams and Wilkins Ltd.出版商出版，收稿方向涵蓋醫學 - 精神病學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 12周，或約稿 ，影響因子指數2.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。